The article highlights Boston Scientific's exceptional performance over the past decade, emphasizing the company's ability to generate substantial returns for its investors. This historical performance, especially when compared to the broader market, suggests a strong operational and financial foundation. Such a track record can positively influence investor sentiment and potentially lead to increased demand for BSX shares in the short term, especially among investors looking for proven long-term growth.